 
- 积分
- 3700
- 威望
- 3700
- 包包
- 15164
|
主题:人多能间充质干细胞在不表达IFNγR1信号和IDO前提下抑制PBMCs增殖' }, s6 R4 ]- o- Y1 S1 l$ U5 m
. H4 y. |% C8 h$ w5 M8 M) y说明:原文来自Blood,干细胞之家新闻小组成员deron翻译(转帖请注明)
# _; ?+ Y9 `: |9 ? c3 o
# _9 S3 k) N" L1 S% `+ S2 @翻译内容:
5 K. \9 O( w& U. ~7 O) D多能间充质干细胞(MSCs)抑制体外大多数(如果不是全部的话)外周血单核细胞(PBMC)亚群的增殖、辅助和效应功能。研究者广泛认为这种抑制效应的分子机制涉及干扰素γ(IFNγ)诱导的吲哚胺2,3加双氧酶(IDO)表达。然而,IDO抑制剂不能恢复所有(抑制反应)条件下PBMCs的增殖。更重要的是,IFNγ受体1(R1)缺失的人MSCs与对照组MSCs相比,抑制HLA错配PBMCs的程度接近。与健康MSCs相比,无论IFNγ存在与否,抑或是与HLA错配的PBMCs共培养,我们在IFNγR1缺乏的MSCs中未发现可检测程度的IDO mRNA。基于基因表达谱,我们能够证明胰岛素样生长因子(IGF)结合蛋白参与MSCs的抑制机制。综上所述,人MSCs在无IFNγR1信号和IDO的前提下可以发挥重要的免疫调节功能,这种现象部分是由IGF结合蛋白参与引起。" z3 r2 `, w2 U$ t0 d8 f7 s# C/ R
原摘要:Multipotent mesenchymal stromal cells (MSCs) inhibit proliferation, helper, and effector functions in most if not all peripheral blood mononuclear cell (PBMC) subpopulations in vitro. The molecular mechanism is widely thought to imply tryptophan degradation by the interferon-gamma (IFNgamma)-induced expression of indoleamine 2,3-dioxygenase (IDO). However, IDO inhibitors were not able to restore proliferation of PBMCs in each case. Moreover, human MSCs with an IFNgamma receptor 1 (R1) defect inhibited proliferation of HLA-mismatched PBMCs to a similar extent as control MSCs. In contrast to healthy MSCs, IFNgammaR1-deficient MSCs showed no detectable mRNA for IDO-neither in the absence nor in the presence of recombinant human IFNgamma, nor in coculture with HLA-mismatched PBMCs. Based on gene expression profiling, we were able to show that insulin-like growth factor (IGF)-binding proteins contribute to the inhibitory mechanism of MSCs. Taken together, human MSCs exert important immunomodulatory functions in the absence of IFNgammaR1 signaling and IDO, partially accounted for by IGF-binding proteins.
+ ?" |6 W$ L, P4 q+ L& F" o
. I$ l# w9 H+ ?# V原文:(364.12 KB, 下载次数: 32) |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 威望 + 20
包包 + 100
查看全部评分
|